Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR alpha/gamma agonist, and its major human metabolite

Bopst, M; Atzpodien, EA

Bopst, M (reprint author), F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev Pharmaceut Sci, Grenzacherstr 124, CH-4070 Basel, Switzerland.

REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017; 86 ( ): 107

Abstract

The non-clinical safety profile of aleglitazar, a peroxisome proliferator activated receptor alpha gamma agonist, and its major human metabolite M6 wa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索